论文部分内容阅读
目的探讨电子化临床路径对输尿管结石单病种治疗的效果。方法选择2013年8月至2014年8月间输尿管结石单病种228份病例随机分为对照组和观察组,对平均住院时间、平均住院费用、并发症、复发率和满意度等进行对比分析。结果观察组与对照组的住院时间分别为7.52±0.18天和8.67±0.24天(P<0.05),住院费用分别为6752.09±169.21元与7892.63±377.33元(P<0.05),满意度分别为98.05±0.31分与93.16±0.78分(P<0.05),并发症发生率分别为5.00%与6.49%(P>0.05),复发率分别为0.84%与10.19%(P<0.05)。结论电子化临床路径管理实施能有效缩短平均住院日,降低医疗费用,保证医疗质量,预防结石复发,提高病人满意度,具备良好的临床疗效和社会效益,值得临床推广。
Objective To investigate the effect of electronic clinical pathway on the treatment of ureteral calculi single disease. Methods A total of 228 cases of single disease of ureteral calculi between August 2013 and August 2014 were randomly divided into control group and observation group. The mean length of hospital stay, average hospitalization expenses, complications, recurrence rate and satisfaction were compared . Results The hospitalization time was 7.52 ± 0.18 days and 8.67 ± 0.24 days respectively in the observation group and the control group (P <0.05), and the hospitalization costs were 6752.09 ± 169.21 yuan and 7892.63 ± 377.33 yuan respectively (P <0.05), and the satisfaction rates were 98.05 ± 0.31 and 93.16 ± 0.78 respectively (P <0.05). The complication rates were 5.00% and 6.49% respectively (P> 0.05). The recurrence rates were 0.84% and 10.19% (P <0.05). Conclusion The implementation of electronic clinical path management can effectively shorten the average length of stay, reduce medical costs, ensure the quality of medical treatment, prevent the recurrence of stones and improve patient satisfaction with good clinical and social benefits. It is worthy of clinical promotion.